Innealta Capital’s Anterix ATEX Stock Holding History

Innealta Capital’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11	Closed	-$435	–	275
2024 Q2	$435	Buy	+11	New	+$356	﹤0.01%	1496

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Innealta Capital's ATEX Position: Q3 2024 in Review

Innealta Capital sold out of Anterix (ATEX) in Q3 2024, closing a stake of 11 shares — an estimated $435 sold.

Innealta Capital first reported a position in ATEX in Q2 2024 and held it in 1 quarter. The position peaked at $435 in Q2 2024. 129 funds tracked by Wall St. Rank hold ATEX as of Q3 2024.

Innealta Capital reported no remaining Anterix position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 11 Anterix shares in Q3 2024, an estimated $435.
Innealta Capital first reported a position in Anterix in Q2 2024 and held it in 1 quarter.
Innealta Capital's Anterix position peaked at $435 in Q2 2024.
129 funds tracked by Wall St. Rank held Anterix as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.